| 000 | 01759 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514233146.0 | ||
| 264 | 0 | _c20051209 | |
| 008 | 200512s 0 0 fre d | ||
| 022 | _a1278-3218 | ||
| 024 | 7 |
_a10.1016/j.canrad.2005.06.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMilbéo, Y | |
| 245 | 0 | 0 |
_a[Adjuvant radiation therapy for soft tissue sarcoma of the extremities: analysis of local control according to volume and dose]. _h[electronic resource] |
| 260 |
_bCancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique _cSep 2005 |
||
| 300 |
_a293-303 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 | _aExtremities |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aFrance _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLimb Salvage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xepidemiology |
| 650 | 0 | 4 | _aNeoplasm, Residual |
| 650 | 0 | 4 | _aRadiotherapy Dosage |
| 650 | 0 | 4 |
_aRadiotherapy, Adjuvant _xadverse effects |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aSarcoma _xmortality |
| 650 | 0 | 4 |
_aSoft Tissue Neoplasms _xmortality |
| 650 | 0 | 4 | _aSurvival Analysis |
| 700 | 1 | _aKantor, G | |
| 700 | 1 | _aLaharie, H | |
| 700 | 1 | _aLagarde, P | |
| 700 | 1 | _aStoeckle, E | |
| 700 | 1 | _aBonichon, F | |
| 700 | 1 | _aThomas, L | |
| 700 | 1 | _aBrouste, V | |
| 700 | 1 | _aBui, B N | |
| 773 | 0 |
_tCancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique _gvol. 9 _gno. 5 _gp. 293-303 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.canrad.2005.06.001 _zAvailable from publisher's website |
| 999 |
_c15661910 _d15661910 |
||